home / stock / asnd / asnd message board
Subject | By | Source | When |
---|---|---|---|
Short today at 85.34 | MiamiGent | investorshub | 05/01/2023 8:42:43 PM |
Ascendis Pharma: FDA Approves Skytrofa to Treat Pediatric | crudeoil24 | investorshub | 08/25/2021 9:19:58 PM |
ASCENDIS PHARMA A/S is a Danish-based biopharmaceutical company, | crudeoil24 | investorshub | 08/25/2021 9:17:30 PM |
News, Short Squeeze, Breakout and More Instantly...
COPENHAGEN, Denmark, April 24, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the United Kingdom’s Medicines & Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for YORVIPATH ® (palopegteriparatide; developed as ...
2024-04-19 17:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Ascendis Pharma (NASDAQ:ASND) has outperformed the market over the past 15 years by 17.87% on an annualized basis producing an average annual retur...